**Variable Descriptions:**

patient_id: Unique patient identifier.

treatment: Treatment modality (radiotherapy, radiochemotherapy, Radio+EGFRI).

age: Age at diagnosis in years.

sex: Biological sex of the patient.

ECOG: ECOG performance status (functional ability, 0–4 scale).

Smoking Status: Categorical smoking history (never, former, current).

Smoking PY: Pack-years of smoking exposure.

DS Site: Major tumor site (e.g., oropharynx, larynx, etc.).

Subsite: Specific tumor subsite within the primary region.

T: Tumor (T) stage from TNM classification.

N: Nodal (N) stage from TNM classification.

M: Metastasis (M) stage from TNM classification.

Stage: Overall clinical stage (I–IV).
path: Tumor histopathology or disease subtype.

hpv: HPV status (positive, negative, or unknown).

tx modality: Treatment modality (e.g., radiotherapy alone, chemoradiotherapy).

chemo: Indicator for chemotherapy administration (yes/no).

rt start: Start date of radiotherapy.

dose: Total radiation dose delivered (in Gray, Gy).

fx: Number of radiation fractions (sessions).

last fu: Date of last clinical follow-up.

status: Vital status at last follow-up (alive/deceased).

length fu: Duration of follow-up (days).

date of death: Date of death (if applicable).

cause of death: Cause of death (disease-related or other).

local: Local recurrence indicator (yes/no).

date local: Date of local recurrence.

regional: Regional recurrence indicator (yes/no).

date regional: Date of regional recurrence.

distant: Distant metastasis indicator (yes/no).

date distant: Date of distant metastasis.

2nd ca: Indicator for second primary cancer.

date 2nd ca: Date of second primary cancer diagnosis.

radcure-challenge: Flag for cases included in the RadCure ML Challenge dataset.

contrastenhanced: Indicates whether diagnostic imaging was contrast-enhanced.
